Ephrin-A1 expression contributes to the malignant characteristics of α-fetoprotein producing hepatocellular carcinoma

Hidehiro Iida, Masayuki Honda, Hiroshi Kawai, +5

Gut

Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety

Yuya NAKAMOTO, Eishiro Mizukoshi, Hirokazu Tsuji, +9

Clinical & Experimental Immunology

Cytokine profile of macrophage activation syndrome associated with Kawasaki disease

Asumi Jinkawa, Masaki Shimizu, Keigo Nishida, +10

Cytokine

InflammationCytokineAutoimmune DiseaseGranulocyteImmune Cell Development +9

Severe Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Deceased-donor and Living-donor Liver Transplantation

Hiroyuki Takamura, Shinichi Nakanuma, Hironori Hayashi, +27

Transplantation Proceedings

TransplantationHepatologyPathologyLiving-donor Liver TransplantationTransplant Surgery +4

Distant metastasis of hepatocellular carcinoma after successful treatment of the primary lesion.

Yutaka Inagaki, Masashi Unoura, Takeshi Urabe, +7

PubMed

Surgical OncologyDistant MetastasisPathologyPrimary LesionOncology +14

Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers

Shuya Kaneko, Masaki Shimizu, Asami Shimbo, +18

Cytokine

InflammationCytokineAutoimmune DiseaseImmunodeficienciesPathogenesis +6

Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch–Schönlein purpura nephritis

Hitoshi Irabu, Masaki Shimizu, Shuya Kaneko, +6

Pediatric Research

ApoptosisRenal PathologyRenal InflammationCell DeathPathology +16

Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy

Hitoshi Irabu, Masaki Shimizu, Shuya Kaneko, +4

Pediatric Research

InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseTocilizumab Therapy +12

Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function

Shuya Kaneko, Fumiaki Sakura, Kay Tanita, +15

Immunotherapy Advances